These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2765824)

  • 1. Recessive mutation, chromosome deletion and cancer.
    Thompson AM; Steel CM; Carter DC
    Br J Surg; 1989 Jul; 76(7):765. PubMed ID: 2765824
    [No Abstract]   [Full Text] [Related]  

  • 2. Recessive mutations and chromosome deletions leading to cancer.
    Berne J; McColl I; Adinolfi M
    Br J Surg; 1989 Apr; 76(4):327-30. PubMed ID: 2655817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary cancers disclose a class of cancer genes.
    Knudson AG
    Cancer; 1989 May; 63(10):1888-91. PubMed ID: 2702563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recessive oncogene and loss of heterozygosity].
    Sasaki M; Ejima Y; Ishizaki K; Toguchida J; Kato M
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):624-31. PubMed ID: 2650634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workshop report from the Division of Research Grants, National Institutes of Health. The role of chromosome rearrangements, deletions, and point mutations in cancer--a Pathology B Study Section workshop.
    Isom H; Kitchingman G; Roy-Burman P; Fausto N; Padarathsingh M
    Cancer Res; 1991 Oct; 51(19):5440-4. PubMed ID: 1913663
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of human cancer.
    Knudson AG
    Annu Rev Genet; 1986; 20():231-51. PubMed ID: 2880556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chromosome-breakage syndromes: rare disorders that provide models for studying somatic mutation.
    German J
    Birth Defects Orig Artic Ser; 1990; 26(1):85-111. PubMed ID: 2224081
    [No Abstract]   [Full Text] [Related]  

  • 8. Many gene changes found in cancer.
    Marx J
    Science; 1989 Dec; 246(4936):1386-8. PubMed ID: 2595361
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of deletions in spontaneous and induced mutations associated with movement of transposable DNA elements: possible implications for evolution and cancer.
    MacPhee DG
    Mutat Res; 1991; 250(1-2):35-47. PubMed ID: 1658640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetics and cancer].
    Cardesa JJ; Blesa E; Durán J; Moreno F; Espinosa J; Zarallo L
    An Esp Pediatr; 1985 Aug; 23(2):116-22. PubMed ID: 2998249
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular markers of cancer.
    Ross DW
    Arch Pathol Lab Med; 1991 Apr; 115(4):402. PubMed ID: 2012504
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer genetics. Genomic imprinting and embryonal tumours.
    Reik W; Surani MA
    Nature; 1989 Mar; 338(6211):112-3. PubMed ID: 2918934
    [No Abstract]   [Full Text] [Related]  

  • 13. [Search for tumor suppressor genes: chromosome deletions and loss of heterozygote property in human tumors].
    Berger R
    Bull Cancer; 1993 Aug; 80(8):713-6. PubMed ID: 8204953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing concepts in mutation research.
    Sobels FH
    Prog Clin Biol Res; 1986; 209A():129-46. PubMed ID: 3018767
    [No Abstract]   [Full Text] [Related]  

  • 15. Persons at high risk of cancer.
    Knudson AG
    N Engl J Med; 1979 Sep; 301(11):606-7. PubMed ID: 470983
    [No Abstract]   [Full Text] [Related]  

  • 16. Deletion of genes on chromosome 1 in endocrine neoplasia.
    Mathew CG; Smith BA; Thorpe K; Wong Z; Royle NJ; Jeffreys AJ; Ponder BA
    Nature; 1987 Aug 6-12; 328(6130):524-6. PubMed ID: 3614355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of constitutional heterozygosity in human cancer.
    Lasko D; Cavenee W; Nordenskjöld M
    Annu Rev Genet; 1991; 25():281-314. PubMed ID: 1687498
    [No Abstract]   [Full Text] [Related]  

  • 18. The molecular biology of human cancer.
    Feinberg AP
    Prog Clin Biol Res; 1985; 198():279-92. PubMed ID: 4070309
    [No Abstract]   [Full Text] [Related]  

  • 19. Rates of p16 (MTS1) mutations in primary tumors with 9p loss.
    Cairns P; Mao L; Merlo A; Lee DJ; Schwab D; Eby Y; Tokino K; van der Riet P; Blaugrund JE; Sidransky D
    Science; 1994 Jul; 265(5170):415-7. PubMed ID: 8023167
    [No Abstract]   [Full Text] [Related]  

  • 20. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
    Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.